Oligometastasis to testis in prostate cancer: Role of gallium-68 prostate-specific membrane antigen positron-emission tomography computed tomography

Oligometastasis to testis in prostate cancer: Role of gallium-68 prostate-specific membrane antigen positron-emission tomography computed tomography

Accurate staging and restaging with early detection of recurrent site is the key for planning treatment in patients of prostate cancer. Recently, gallium-68 prostate-specific membrane antigen positron-emission tomography computed tomography (68Ga-PSMA PET/CT) has emerged as a better tool for this. F...

Full description

Saved in:

Bibliographic Details
Main Authors:	Manoj Gupta, Partha Choudhury, Sudhir Rawal, Amitabh Singh
Format:	Article
Language:	English
Published:	Thieme Medical and Scientific Publishers Pvt. Ltd. 2021-03-01
Series:	World Journal of Nuclear Medicine
Subjects:	gallium-68 prostate-specific membrane antigen positron-emission tomography computed tomography oligometastasis prostate cancer testicular metastasis
Online Access:	http://www.thieme-connect.de/DOI/DOI?10.4103/wjnm.WJNM_39_20
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Gallium-68 prostate-specific membrane antigen positron emission tomography/computed tomography compared with diagnostic computed tomography in relapsed prostate cancer
by: Marcus Edward Asokendaran, et al.
Published: (2019-07-01)

A comparative study of 68Gallium-prostate specific membrane antigen positron emission tomography-computed tomography and magnetic resonance imaging for lymph node staging in high risk prostate cancer patients: An initial experience
by: Manoj Gupta, et al.
Published: (2017-07-01)

False-positive prostate cancer bone metastases on magnetic resonance imaging correctly classified on gallium-68-prostate-specific membrane antigen positron emission tomography computed tomography
by: Sofiullah Abubakar, et al.
Published: (2018-10-01)

Neuroendocrine prostate cancer or prostatitis? An unusual false positive on gallium-68 DOTA-Tyr3-octreotate positron emission tomography/computed tomography in a patient with known metastatic neuroendocrine tumor
by: Matthew Q Schmidt, et al.
Published: (2019-07-01)

Initial experience of Ga-68 prostate-specific membrane antigen positron emission tomography/computed tomography imaging in evaluation of biochemical recurrence in prostate cancer patients
by: Aravintho Natarajan, et al.
Published: (2019-07-01)

A case of hepatic focal nodular hyperplasia mimicking hepatocellular carcinoma identified on gallium-68-prostate-specific membrane antigen positron emission tomography/computed tomography
by: Seckin Bilgic, et al.
Published: (2021-04-01)

Can gallium-68 prostate-specific membrane antigen ligand be a potential radiotracer for renal cortical positron emission tomography imaging?
by: Ismet Sarikaya, et al.
Published: (2018-04-01)

68 Ga-prostate-specific membrane antigen positron emission tomography/computed tomography for prostate cancer imaging: A narrative literature review
by: Jose Oliveira, et al.
Published: (2017-01-01)

Initial risk stratification and staging in prostate cancer with prostatic-specific membrane antigen positron emission tomography/computed tomography: A first-stop-shop
by: Manoj Gupta, et al.
Published: (2018-10-01)

Fluorodeoxyglucose, sodium fluoride, and prostate-specific membrane antigen positron emission tomography studies for treatment response assessment in prostate cancer
by: Ismet Sarikaya, et al.
Published: (2018-07-01)

Gallium-68 Dota-Tate positron emission tomography/computed tomography: Scintigraphic changes of adrenal glands following management of ectopic cushing′s syndrome by steroidogenesis inhibitors
by: Yu-Ting Huang, et al.
Published: (2014-07-01)

Isolated aplasia of submandibular salivary gland and contralateral prominence of submandibular and sublingual salivary glands incidentally found on 68Ga-prostate-specific membrane antigen positron emission tomography—computed tomography
by: Abbas Yousefi-Koma, et al.
Published: (2020-07-01)

Occult prostate cancer detected with 18F-fluorocholine positron emission tomography/computed tomography
by: Wanying Xie, et al.
Published: (2014-07-01)

Prostate-specific antigen cutoff value for ordering sodium fluoride positron emission tomography/computed tomography bone scan in patients with prostate cancer
by: Ismet Sarikaya, et al.
Published: (2018-10-01)

How Does Routine Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography Modify the Current Management of Prostate Cancer? A Multidisciplinary View
by: Daniela E. Oprea-Lager, et al.
Published: (2025-05-01)

Fibrous dysplasia as a possible false-positive finding in 68Ga-labeled prostate-specific membrane antigen positron emission tomography/computed tomography study in the follow-up of prostate cancer
by: André Marcondes Braga Ribeiro, et al.
Published: (2019-10-01)

Vas deferens infiltration by prostate cancer on prostate-specific membrane antigen-targeted 18F-DCFPyL positron emission tomography/computed tomography: A unique visual pattern
by: Yafu Yin, et al.
Published: (2019-10-01)

Extrapleural solitary fibrous tumor evidenced by 68Ga-prostate-specific membrane antigen positron emission tomography/computed tomography study in the staging of a high-risk prostate cancer patient
by: André Braga Ribeiro, et al.
Published: (2020-10-01)

Enhancing Prostate Cancer Detection: Integrating Multiparametric Magnetic Resonance Imaging and 68Ga-prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography with Machine Learning
by: Mohammad Hossein Sadeghi, et al.
Published: (2025-04-01)

18F-prostate-specific membrane antigen positron emission tomography computed tomography incidental finding in a patient after COVID-19 infection
by: Siroos Mirzaei, et al.
Published: (2020-10-01)

COMPUTER TOMOGRAPHY IN DIAGNOSIS OF DISEASES AND NEW FORMATIONS OF THE PROSTATE GLAND
by: D. E. Baikov, et al.
Published: (2017-07-01)

The risk of prostate cancer on incidental finding of an avid prostate uptake on 2-deoxy-2-[18F]fluoro-d-glucose positron emission tomography/computed tomography for non-prostate cancer-related pathology: A single centre retrospective study
by: Anthony Franklin, et al.
Published: (2024-01-01)

High Detection Rates for Prostate-specific Membrane Antigen–avid Prostate Cancer Recurrence at Low Prostate-specific Antigen levels on Extended Axial Field-of-view Positron Emission Tomography/Computed Tomography
by: Sarah Thomas, et al.
Published: (2025-01-01)

Prostate-specific antigen and prostate-specific antigen kinetics in predicting 18F-sodium fluoride positron emission tomography-computed tomography positivity forfirst bone metastases in patients with biochemical recurrence after radical prostatectomy
by: James Yoon, et al.
Published: (2017-07-01)

Comparison of 18F-FDG and 68-PSMA-11 in PET for prostate cancer diagnosis
by: Natalia Fulle, et al.
Published: (2022-12-01)

Updates on controversies surrounding the staging and management of newly diagnosed localized prostate cancer using prostate-specific membrane antigen (PSMA) positron emission tomography
by: Patricia Tai, et al.
Published: (2025-07-01)

A case of well-differentiated hepatocellular carcinoma identified on gallium-68 prostate-specific membrane antigen positron emission tomography/computed tomography
by: Hian Huang, et al.
Published: (2018-04-01)

A comparison of routine [68Ga]Ga-PSMA-11 preparation using Locametz and Illuccix kits
by: Ivan E. Wang, et al.
Published: (2024-12-01)

Bounce effect or local recurrence after low-dose-rate brachytherapy of the prostate? When prostate-specific membrane antigen positron emission tomography–computed tomography is false positive: a case report
by: Tamas Rozsos, et al.
Published: (2025-05-01)

An overview on prostate-specific membrane antigen uptake in malignancies other than prostate cancer: A pictorial essay
by: Esmail Jafari, et al.
Published: (2020-07-01)

Is Copper-61 the New Gallium-68? Automation and Preclinical Proof-of-Concept of <sup>61</sup>Cu-Based Radiopharmaceuticals for Prostate Cancer Imaging
by: Diana Rodrigues, et al.
Published: (2025-03-01)

Quality control and GMP synthesis of 68Ga-prostate-specific membrane antigen-11 for detection of low- and high-grade prostate cancer
by: Majid Assadi, et al.
Published: (2020-04-01)

Revolutionizing Prostate Cancer Detection: The Role of Approved PSMA-PET Imaging Agents
by: Ute Hennrich, et al.
Published: (2025-06-01)

Diagnosis and clinical significance of prostate calcification using computed tomography
by: Seong Cheol Kim, et al.
Published: (2025-02-01)

Incidental detection of asymptomatic brain metastases on 18F-fluoride positron emission tomography/computed tomography and 68Ga DOTANOC positron emission tomography/computed tomography in a patient with concomitant breast carcinoma and a pancreatic neuroendocrine tumor
by: Ruth Brown, et al.
Published: (2018-01-01)

COVID-19 messenger ribonucleic acid vaccination and abnormal radiopharmaceutical uptake in the axilla visualized on 68Ga-DOTATATE positron-emission tomography/computed tomography
by: Joshua Weissman, et al.
Published: (2021-10-01)

F-18 fluorocholine positron emission tomography–computed tomography in initial staging and recurrence evaluation of prostate carcinoma: A prospective comparative study with diffusion-weighted magnetic resonance imaging and whole-body skeletal scintigraphy
by: Rakhee Vatsa, et al.
Published: (2021-04-01)

OPTIMIZATION OF PRIMARY TRANSRECTAL MULTIFOCAL PROSTATE BIOPSY USING PERFUSION COMPUTED TOMOGRAPHY
by: N. V. Sosnovskiy, et al.
Published: (2018-11-01)

Computed tomography imaging analysis of hematogenous disseminated pulmonary tuberculosis cases combined with prostate tuberculosis
by: Xu-Wen Fu, et al.
Published: (2025-07-01)

Unexpected discovery of hepatic cancer via 68Ga-PSMA PET/CT in the staging of prostate cancer
by: Radu Alexa, et al.
Published: (2025-06-01)